1,567
edits
m (→Guidelines) |
(→Design) |
||
Line 49: | Line 49: | ||
==Design== | ==Design== | ||
* Multicenter, double-blind, 2-by-2 factorial, randomized trial | |||
* N=1241 | |||
* Multicenter, double-blind, | |||
* N= | |||
** Intervention (n=) | ** Intervention (n=) | ||
** Placebo (n=) | ** Placebo (n=) | ||
Line 59: | Line 57: | ||
* Mean follow-up: | * Mean follow-up: | ||
* Analysis: | * Analysis: | ||
* Primary Outcome: | * Primary Outcome: 90-day all-cause mortality | ||
==Population== | ==Population== |
edits